BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 30, 2018
View Archived Issues
Alnylam Pharmaceuticals presents novel siRNAs for muscle atrophy
Read More
University of Pennsylvania divulges ZEBOV-targeting antibodies
Read More
Enterome patents antigenic peptides for cancer
Read More
Clinical study shows potential of ranolazine in paramyotonia congenita
Read More
REGN-4659 demonstrates antitumor activity in vivo
Read More
Janssen monoclonal antibody JNJ-64164711 depletes Tregs in tumor samples
Read More
ITI-214, a potential candidate for the treatment of Parkinson's disease
Read More
Biktarvy granted positive opinion in Europe
Read More
EMA's CHMP adopts positive opinion for Dzuveo
Read More
INSYS initiates phase II study of cannabidiol oral solution for treatment of Prader-Willi syndrome
Read More
Tagrisso receives positive opinion in Europe for first-line EGFR-mutated NSCLC
Read More
DisperSol initiates phase II trials of DST-0509 in iron overload disorder
Read More
Advantagene and BMS enter clinical trial collaboration
Read More
EMA committee recommends approval of Prolia for bone loss associated with glucocorticoid therapy
Read More
EMA committee hands down positive opinion for Cimzia in moderate to severe plaque psoriasis
Read More
FDA grants orphan drug designation to ELX-02 for cystinosis
Read More
Enrollment open in phase II study of dutogliptin for early recovery post-myocardial infarction
Read More
Bolder completes phase I study of long-acting G-CSF analogue BBT-015
Read More
FDA grants priority review to cemiplimab BLA for metastatic or advanced CSCC
Read More
Photoacoustic imaging agents for Alzheimer's disease described in KAERI patent
Read More
Chinese researchers patent deuterated derivatives of vonoprazan fumarate
Read More
AbbVie reviews milestones of first quarter 2018
Read More
WXFL-1024H251 demonstrates promising antitumor activity in breast and lung cancer models
Read More
ACHIEVE II study of ubrogepant in acute migraine meets coprimary endpoints
Read More
Accelerator Life Science Partners launches Proniras
Read More